Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Return on Sales (2016 - 2025)

Lisata Therapeutics' Return on Sales history spans 12 years, with the latest figure at 29.54% for Q4 2025.

  • For Q4 2025, Return on Sales fell 2493.0% year-over-year to 29.54%; the TTM value through Dec 2025 reached 97.56%, down 7758.0%, while the annual FY2025 figure was 97.56%, 7758.0% down from the prior year.
  • Return on Sales reached 29.54% in Q4 2025 per LSTA's latest filing, down from 17.05% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 4.61% in Q4 2024 to a low of 66.56% in Q2 2025.